Dual oxidase 2 (
DUOX2) generates H2O2 that plays a critical role in both host defense and chronic
inflammation. Previously, we demonstrated that the proinflammatory mediators IFN-γ and LPS enhance expression of
DUOX2 and its maturation factor DUOXA2 through STAT1- and NF-κB‒mediated signaling in human
pancreatic cancer cells. Using a panel of colon and
pancreatic cancer cell lines, we now report the induction of
DUOX2/DUOXA2
mRNA and
protein expression by the TH2
cytokine IL-4.
IL-4 activated STAT6 signaling that, when silenced, significantly decreased induction of
DUOX2. Furthermore, the TH17
cytokine IL-17A combined synergistically with
IL-4 to increase
DUOX2 expression in both colon and
pancreatic cancer cells mediated, at least in part, by signaling through NF-κB. The upregulation of
DUOX2 was associated with a significant increase in the production of extracellular H2O2 and DNA damage-as indicated by the accumulation of
8-oxo-dG and γH2AX-which was suppressed by the
NADPH oxidase inhibitor
diphenylene iodonium and a DUOX2-specific
small interfering RNA. The clinical relevance of these experiments is suggested by immunohistochemical, microarray, and quantitative RT-PCR studies of human colon and pancreatic
tumors demonstrating significantly higher
DUOX2, IL-4R, and IL-17RA expression in
tumors than in adjacent normal tissues; in pancreatic
adenocarcinoma, increased
DUOX2 expression is adversely associated with overall patient survival. These data suggest a functional association between DUOX2-mediated H2O2 production and induced DNA damage in gastrointestinal
malignancies.